SEC Form D · filed August 10, 2022
Nuvectis Pharma, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (14)
Matthew Kaplan · NEW YORK, NYDirectorJames Oliviero · Fort Lee, NJDirectorEnrique Poradosu · Fort Lee, NJExecMichael Carson · Fort Lee, NJExecKenneth Hoberman · Fort Lee, NJDirectorRon Bentsur · Ness Ziona, L3Exec · DirectorShay Shemesh · Fort Lee, NJExecJames Oliviero · Fort Lee, NJDirectorEnrique Poradosu · Fort Lee, NJExecMatthew Kaplan · New York, NYDirectorMichael Carson · Fort Lee, NJExecKenneth Hoberman · Fort Lee, NJDirectorRon Bentsur · Ness Ziona, L3Exec · DirectorShay Shemesh · Fort Lee, NJExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗